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Epidermolytic hyperkeratosis is caused by mutations of the 
differentiation-specific keratins Kl and KlO. These muta-
tions produce a weakened cytoskeleton that is prone to col-
lapse resulting in cell fragility and lysis . In this study we have 
analyzed cultured keratinocytes from EHK patients bearing 
tOR-to-H and 15L-to-S mutations within the lA segment of 
the KlO rod domain. Keratinocytes were grown submerged 
in serum-free medium and induced to differentiate by grow-
ing to confluence and increasing the Ca++ concentration in 
the medium. Cultures were either harvested for mRNA se-
quence analysis or subjected to immunofluorescence micros-
copy. Differentiating keratinocytes from these patients were 
E pidermolytic hyperkeratosis (EHK) [1] or bullous con-genital ichthyosiform erythroderma (BCIE) [2] is an au-tosomal dominant genodermatosis [3] clinically charac-terized initially by erythematous blisters that decrease with age and later on by the formation of hyperkera-
toses. EHK is characterized histologically by a marked expansion of 
the granular and stratum corneum layers [1] and granular degenera-
tion in the Malpighian layer that correspond ultrastructurally to a 
collapsed keratin intermediate filaments (KIF) network [4]. The 
collapsed KIF network in the suprabasal layers suggested that a 
defect in the differentiation-specific keratins, K1 and KI0, was in-
volved in EHK. In fact, specific antibodies directed against these 
keratins selectively labeled the clumped keratin aggregates of EHK 
keratinocytes [5] . Most recently, genetic linkage of EHK to the 
keratin chromosomal loci was reported [6] and point mutations in 
Kl and KI0 genes were identified as causative for the disease [7 -9] . 
Keratins are members of the intermediate fi lament superfamily 
that share a common structure consisting of a central a-helical rod-
shaped domain that is flanked by globular end-domains (heads and 
tails) [10]. The central rod domain consists of four a-helical tracts 
that possess a quasi-heptad sequence with hydrophobic residues 
found at positions one and four of the repeating heptads [10]. The 
a-helical tracts appear to be crucial for fi lament assembly and stabil-
ity, whereas the globular end-domains are believed to contribute to 
supernumerary functions specific for each intermediate filament 
type. KIF are the major components of the cytoskeleton of epithelial 
cells and are encoded by a fami ly of approximately 25 to 30 genes. 
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found to express these K1 0 mutations in their mRNA. More-
over, these cells could be distinguished from normal kerati-
nocytes by their aberrrant morphology. EHK keratinocytes 
frequently exhibited a collapsed perinuclear network ofKl/ 
KlO filaments and sometimes peripheral granules of Kl and 
KlO aggregates, reminiscent of the cells of the suprabasal 
layers in these patients. This report documents the expression 
of mutant keratin 10 in cultured EHK keratinocytes. Key 
words: epidermolytic hyperkeratosis/bullous cottgenital ichthyosi-
form erythroderma/keratitt/intermediate jilaments/keratittocyte/ 
epidermis. ] Invest Dermatol1 02:691- 694, 1994 
They can be divided into two major groups, the acidic and the 
neutral-basic subfamilies, which are now defined as types I and II, 
respectively [10,11]. Most human genes encoding individual kera-
tins have been identified, sequenced, and mapped. The genes en-
coding type I keratins are clustered on human chromosome 17q, and 
the genes encoding type II lie on chromosome 12q (for references 
see [12]). In contrast to other intermediate filaments that form 
homopolymers, individual cells within an epithelial tissue express at 
least one type I and one type II keratin (reviewed in [10]). The first 
hierarchical step of KIF polymerization involves the formation of 
coiled-coil heterodimers consisting of type I and type II keratin 
molecules that align stably as antiparallel tetrameres [13-15]. Such 
tetrameres constitute the building blocks for the late stages of as-
sembly into 10-nm cytoplasmic filaments [15,16] . 
Mutations in critical regions within keratin molecules are 
thought to interfere with this assembly process or severely affect the 
stability of their associations, resulting in a weakened filament. In-
deed the introduction of mutant K14 molecules, with C- and/or 
N-terminal deletions of their a-helical rod domain, into cultured 
keratinocytes caused the disruption of the endogenous KIF network 
with the appearance of cytoplasmic keratin granules and perinuclear 
filament collapse [17 ,18]. Recently, several mutations have been 
identified in the genes encoding for the keratins K5 and K14 in 
patients with epidermolysis bullosa simplex [19 - 21]. Cultured ker-
atinocytes from epidermolysis bullosa simplex patients exhibited 
distinct morphologic alterations in their keratin cytoskeleton with 
ball-like keratin aggregates in the cell periphery [22] . Similar 
changes have not been reponed in keratinocyte cultures from EHK 
skin. The present study was undertaken to determine whether kera-
tinocytes cultured from EHK patients express mutant keratin 
mRNA and to identify specific morphologic alterations within 
their suprabasal KIF network. 
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MATERIAL AND METHODS 
Cell Culture Two normal subjects and two EHK patients were selected as 
skin donors. The two EHK patients, WL and OR, exhibited genomic muta-
tions of the Kl0 rod domain lA IOR-to-H and 15L-to-S, respectively [7]. 
Primary human epidermal keratinocytes from all individuals were estab-
lished on 3T3 cell feeder layers according to the Rheinwald and Green 
method and supplemented as described [23]. Secondary or tertiary keratino-
cytes were harvested 4 d post-confluence for mRN A isolation. Alternative! y, 
near confluent primary or secondary keratinocytes were cui tured on cham-
bered glass slides (Lab-Tek, Miles Scientific) and fed with serum-free me-
dium containing 0.09 mM Ca++ (SFM, Gibco Europe Ltd., Paisley, Scot-
land) until 80-90% confluent. At this time cells were either cultured. in the 
same medium or shifted into serum-free medium containing 1.2 mM Ca++. 
At specific time points (0,12,24,48,96, and 168 h) from the Ca++ shift cells 
were fixed in cold methanol and stored at -70· C until analyzed by immu-
nofluorescence. All experiments were repeated at least three times. 
RNA Isolation, Reverse Transcription/PCR, and Sequencing To-
tal RNA was isolated from cultured primary and secondary keratinocytes 
accord ing to the protocol developed by Chomczynski and Sacchi [24]. Ex-
pression of mutant K10 transcripts was analyzed by reverse transcription and 
polymerase chain reaction (PCR) amplification (RT /PCR) followed by sin-
gle-strand sequencing. cDNA synthesis was performed using Avian Mo-
loney virus reverse transcriptase (Life Sciences, Saint Petersburg, FL), ran-
dom hexamer primer (pd(N)6' Pharmacia, LKB Biotechnology Inc., 
Piscataway, N J), and RN asin (Promega Biotec, Madison, WI) and RNA was 
removed as described [25]. This cDNA was then amplified using HK10-spe-
cific oligonucleotides (5' -GAGGAGATGGTG GCCTTCTCTCTGG-3' 
and 5'-GGCATTATCAGTTGTTAGGTTGAG-3') corresponding to bp 
2080- 2105 and to bp 3145 -3168 of the published genomic sequence [26]. 
The 5' oligonucleotide was biotinylated to facilitate template purification 
prior to single-strand sequencing. The 3' oligonucleotide was designed to 
anneal downstream of intron 1 to control against the possibility of amplifi-
cation of genomic DNA sequences. PCR was performed and products were 
purified and sequenced as described [7]. The sequencing primer used was 
5' -GT A TTTGCTTGTAGTCAGG-3' corresponding to bp 2253 - 2270 of 
the published sequence [26]. 
Indirect Immunofluorescence Microscopy Affinity-putified mono-
specific polyclonal antibodies to the carboxy terminal peptides of K1 , K10, 
and K14 were prepared as previously described [27]. Rabbit sera directed 
against K1 and Kl0 were diluted 1 : 200, and the guinea pig antiserum 
against K 14 diluted 1 : 1000. Mouse monoclonal antibodies directed against 
all keratins were purchased from Roche Diagnostica (Lu-5) and used at a 
dilution ofl : 100. Antibodies were visualized using FlTC (Dako, Denmark) 
or Texas Red (BRL, USA) for indirect immunofluorescence microscopy. 
. RESULTS AND DISCUSSION 
Sequence analysis ofK10 mRNA from keratinocytes cultured from 
the two EHK patients revealed a G-to-A substitution at nucleotide 
467 (numbered from the start of translation) in patient WL, which 
results in a IOR_to_H mutation of the KI0 rod domain lA. Similarly, 
in patient OR, a T-to-C substitution was observed at nucleotide 
482, resulting in a 15L_to_S mutation of the Kl 0 rod domain lA (see 
Fig 1). The mutations observed in the mRNA from EHK keratino-
cytes from patients WL and OR confirm the expression of the 
previously reported genomic mutations [7]. 
The morphology of normal proliferating primary keratinocytes, 
maintained in 0.09 mM Ca++ serum-free medium, showed a low 
nuclear-to-cytoplasmic ratio and expression of K5 and K14 that 
resembled a cage-like fibrillar network of KIF (Fig 2A). Under 
these conditions, a low percentage of cells (1- 5%) expressed K1 and 
K10, but when primary keratinocytes were induced to differentiate 
by increasing the Ca++ concentration of the serum-free medium 
from 0 .09 mM to 1.2 mM, this number increased to a maximum of 
30 to 35% at 96 and 168 h post-switch. These cells exhibited a 
characteristic morphology which appeared flattened with an abun-
dant cytoplasm containing a fine fibrillar meshwork of K1 and K10 
bundles (Fig 2B) . In addition, a few small rounded keratinocytes 
(Fig 2C) exhibited a diffuse, homogeneous staining and were 
present at both Ca++ concentrations. In repetitive counting 0[20 
individual microscope fields (200 X magnification) an average of 
35 rounded keratinocytes per 20 fields examined (1.75 cells/field) 
was recorded. This corresponds to an average of 0.4% of the mean 
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Figure 1. Sequence analysis ofKl0 mRNA from two unrelated individuals 
affected by EHK. The patients, EHK-Wand EHK-O, are heterozygous for 
the mutant alleles at lOR and 15L, respectively. These residues lie within the 
helix initiation motif ofK10. The amino acids are numbered with respect co 
the rod domain. The patients EHK-Wand EHK-O are described in Rothna-
gel el al [7]. 
value of all keratinocytes counted (389 cells/field). Finally, low 
nl1l11bers of polygonal cells exhibited punctate staining not only 
with the anti-K14 and Lu-5 antibodies but also with anti-K1 and 
anti-KI0 antibodies in differentiated cultures (Fig 2C). Such peri-
nuclear and punctate KIF granules are frequently observed during 
mitosis in many epithelial cells such as proliferating keratinocytes 
[28-30]. Thus, the staining of these granules with anti-K14 and 
Lu-5 but not with anti-Kl and anti-KI0 antibodies was expected. 
That such nonfilamentous forms of keratin can be composed of Kl 
and K10 in normal keratinocytes (Fig 2C), has not been reported so 
far. We interpret their occurrence as the rare capability of some 
K1-K10 expressing keratinocytes to retain proliferative potential 
(transiently amplifying cells). 
Analysis of proliferating EHK keratinocytes for K5 and K14 gave 
results identical to the fibrillar network of KIF bundles found in 
normal keratinocytes (data not shown). However, significant alter-
ations in the KIF network were observed in differentiating kerati-
nocytes induced to express Kl and KI0. Particularly, an increase in 
the number of rounded cells was found (Fig 2D). The total number 
of these cells increased to 371 cells per 20 fields counted (200 X 
magnification), i.e., 18.5 cells/field. This corresponds to an average 
of 4.6% of the mean value of all keratinocytes counted (401 cells/ 
field). Also, most of these rounded keratinocytes were 2 to 20 times 
larger than the ones observed in cultures of normal keratinocytes 
and revealed a donut-like homogeneous staining of KIF (Fig 2H -L) 
with a negative central spot corresponding to the nucleus. Such 
perinuclear, donut-like KIF staining was never observed during five 
passages analyzed in normal human keratinocytes. In addition, 
within these fields a few smaller keratinocytes were observed with 
an appearance similar to the rounded keratinocytes of normal cul-
tures shown in Fig 2C that exhibited irregular triangular or polygo-
nal surfaces (Fig 2F,G). Otherwise, EHK keratinocytes retained a 
flattened differentiated morphology more characteristic of normal 
keratinocytes, although these cells infrequently exhibited periph-
eral granular Kl and KI0 deposits that were difficult to bring into 
focus and therefore difficult to document accurately (Fig 2E). 
The morphologic changes described in this report in EHK kerati-
nocytes were similar to the ones observed in cultured keratinocytes 
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Figure 2. Indirect immunofluorescence analysis of .cultured keratinocyt~s with the pan-keratin antibody [Lu-5 (A, D, I, L) and ~lOnospec ili.c antibodies 
agai.nst K10 (B, C , E to H, K)]. A-C, normal keratll10cytes; D - L, keratll10cytes from EHK (WL). A and D, B and E show the dtlferent morphology of 
idenrically cultured and stained normal and EHK keratinocytes, respectively. Note the abnormal KIF cytoskeleton ofEHK keratinocytes which appears eithcr 
perinuclear shcll-like (D and H -L) or peripheral and granular (E). Both pathologic phenotypes differ clearly from changes observed in normal keratinocytes 
(C). Bar, 25,um in A, B, and D-F; 10,um in C and H - L. 
from mutant KI transgenic mice characterized by a carboxy-ter-
, minal deletion of the rod domain in the transgene U. Rothnagel and 
D. Roop, unpublished observation}. Thus, the abnormal KIF cyto-
skele ton in EHK is most likely caused by the mutant KIO. The 
occurrence ofkeratinocytes with a collapsed KIF network forming a 
perinuclear, donut-like shell was the most significant morphologic 
finding (Fig 2H -L). Perinuclear collapsed IF are known to occur 
during interphases of some epithelial cells, however, they expose a 
fibrillar, whorl structure [28,29]. The peripheral granular IF aggre-
gates, similar to the ones observed in cultured keratinocytes from 
epidermolysis bullosa simplex [22] , were found rarely (Fig 2E) and 
they differed clearly from the more perinuclear and punctate gran-
ules frequently observed in many epithelial cells during mitosis 
[28-30]' 
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These studies have shown that cultured keratinocytes from EHK 
patients are characterized by distinct morphologic alterations in 
their keratin filament network . Thus, this in vitro protocol could be 
readily adopted to establish a model system ofEHK with which to 
assess novel therapeutic approaches such as gene therapy for the 
treatment of this and other similar keratin disorders. 
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